Global Oseltamivir Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product Type;

Capsule, Suspension, and Other Product Types.

By Applications;

Influenza A, Influenza B, and Other Applications.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn876592699 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Oseltamivir Market (USD Million), 2021 - 2031

In the year 2024, the Global Oseltamivir Market was valued at USD 698.80 million. The size of this market is expected to increase to USD 859.44 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 3.0%.

The global oseltamivir market is experiencing steady growth due to its widespread use in the treatment and prevention of influenza infections, particularly during seasonal outbreaks and pandemics. Oseltamivir, commonly marketed under the brand name Tamiflu, is an antiviral medication that inhibits the activity of the influenza virus by blocking the action of the neuraminidase enzyme, thereby reducing viral replication and spread in the body. As influenza remains a significant public health concern worldwide, with the potential for severe complications and increased mortality, the demand for oseltamivir continues to rise, driving market expansion.

The market growth of oseltamivir is further propelled by its efficacy in reducing the duration and severity of influenza symptoms when administered promptly after symptom onset. Oseltamivir is recommended by healthcare authorities, including the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC), as a first-line treatment for influenza, especially in high-risk populations such as young children, the elderly, and individuals with underlying health conditions. Additionally, oseltamivir is used prophylactically to prevent influenza transmission in close contacts of infected individuals, such as household members and healthcare workers, contributing to its widespread adoption and market demand.

Moreover, the global oseltamivir market benefits from ongoing research and development activities aimed at improving treatment options and expanding indications. Pharmaceutical companies are investing in the development of novel formulations and delivery methods for oseltamivir to enhance patient convenience and compliance. Furthermore, efforts to develop oseltamivir analogs with improved pharmacokinetic properties and efficacy against emerging influenza strains, including avian and pandemic influenza viruses, are underway. As the threat of influenza outbreaks and pandemics persists, the continued innovation and availability of oseltamivir remain essential in combating the global burden of influenza infections and mitigating their impact on public health.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product Type
    2. Market Snapshot, By Applications
    3. Market Snapshot, By Region
  4. Global Oseltamivir Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Widespread influenza outbreaks.
        2. Efficacy in reducing symptom severity.
        3. Recommendations by healthcare authorities.
      2. Restraints
        1. Development of viral resistance.
        2. Side effects and safety concerns.
        3. Competition from alternative treatments.
      3. Opportunities
        1. Research for novel formulations and delivery methods.
        2. Expansion of indications.
        3. Demand during pandemics and seasonal outbreaks.
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Oseltamivir Market, By Product Type, 2021 - 2031 (USD Million)
      1. Capsule
      2. Suspension
      3. Other Product Types
    2. Global Oseltamivir Market, By Applications, 2021 - 2031 (USD Million)
      1. Influenza A
      2. Influenza B
      3. Other Applications
    3. Global Oseltamivir Market, By Geography, 20254 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Roche Holding AG
      2. GlaxoSmithKline plc
      3. Hetero Drugs Ltd.
      4. Natco Pharma Limited
      5. Strides Pharma Science Limited
      6. Cipla Limited
      7. Alvogen
      8. Mylan N.V.
      9. Teva Pharmaceutical Industries Ltd.
      10. Sun Pharmaceutical Industries Ltd
  7. Analyst Views
  8. Future Outlook of the Market